Methuen, MA, United States of America

Pamela McGuiness


Average Co-Inventor Count = 7.1

ph-index = 2

Forward Citations = 45(Granted Patents)


Location History:

  • Metheun, MA (US) (2001)
  • Methuen, MA (US) (2003 - 2009)

Company Filing History:


Years Active: 2001-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pamela McGuiness

Introduction

Pamela McGuiness is a notable inventor based in Methuen, MA (US), recognized for her significant contributions to the field of pharmaceuticals. With a total of 3 patents, her work primarily focuses on developing compounds that have the potential to treat various medical conditions, including cancer and inflammatory disorders.

Latest Patents

Among her latest patents is the invention titled "Eponemycin and epoxomicin analogs and uses thereof." This invention provides compounds with specific formulas that are designed to be used in pharmaceutical compositions for treating cancer and inflammatory disorders, functioning as proteasome inhibitors. Another significant patent is "Immunological adjuvant compounds compositions and methods of use thereof." This invention introduces novel compounds that act as immunological adjuvants when co-administered with antigens, such as vaccines for bacterial and viral diseases. It also includes formulations and methods for immunizing animals using these compounds.

Career Highlights

Throughout her career, Pamela has worked with prominent companies, including Eisai Company, Limited and Eisai R&D Management Co., Ltd. Her experience in these organizations has contributed to her expertise in pharmaceutical research and development.

Collaborations

Pamela has collaborated with esteemed colleagues, including Lynn D Hawkins and Sally T Ishizaka, enhancing her innovative work through teamwork and shared knowledge.

Conclusion

Pamela McGuiness stands out as a dedicated inventor whose work has the potential to impact the medical field significantly. Her patents reflect her commitment to advancing pharmaceutical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…